Repro Med Systems/KRMD

13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1YMAX

About Repro Med Systems

KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

Ticker

KRMD

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Linda Tharby

Employees

82

Headquarters

Mahwah, United States

KRMD Metrics

BasicAdvanced
$97M
Market cap
-
P/E ratio
-$0.29
EPS
0.58
Beta
-
Dividend rate
$97M
0.58117
$4.30
$1.98
148K
4.014
3.365
1.508
2.921
-40.35%
-54.24%
-47.06%
3.324
5.094
5.304
0.96%
-53.89%
5.66%

What the Analysts think about KRMD

Analyst Ratings

Majority rating from 5 analysts.
Buy

KRMD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-23.45% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$8.1M
14.08%
Net income
-$1.9M
-74.32%
Profit margin
-23.45%
-77.50%

KRMD Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 5.26%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.05
-$0.03
-$0.16
-$0.04
-
Expected
-$0.06
-$0.05
-$0.04
-$0.04
-$0.04
Surprise
-11.77%
-40.00%
300.00%
5.26%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Repro Med Systems stock?

Repro Med Systems (KRMD) has a market cap of $97M as of June 17, 2024.

What is the P/E ratio for Repro Med Systems stock?

The price to earnings (P/E) ratio for Repro Med Systems (KRMD) stock is 0 as of June 17, 2024.

Does Repro Med Systems stock pay dividends?

No, Repro Med Systems (KRMD) stock does not pay dividends to its shareholders as of June 17, 2024.

When is the next Repro Med Systems dividend payment date?

Repro Med Systems (KRMD) stock does not pay dividends to its shareholders.

What is the beta indicator for Repro Med Systems?

Repro Med Systems (KRMD) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Repro Med Systems stock price target?

The target price for Repro Med Systems (KRMD) stock is $3.5, which is NaN% below the current price of $. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Repro Med Systems stock

Buy or sell Repro Med Systems stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing